Evaluation of the relationship between mast cell activation and postural orthostatic tachycardia syndrome in children and adolescents.

Autor:	Bayrak YE; Department of Pediatrics, Kocaeli University Faculty of Medicine, Kocaeli, Turkiye., Kayabey O; Department of Pediatric Cardiology, Kocaeli University Faculty of Medicine, Kocaeli, Turkiye., Basar EZ; Department of Pediatric Cardiology, Kocaeli University Faculty of Medicine, Kocaeli, Turkiye., Simsek IE; Department of Pediatric Immunology and Allergy, Kocaeli University Faculty of Medicine, Kocaeli, Turkiye., Aydogan M; Department of Pediatric Immunology and Allergy, Kocaeli University Faculty of Medicine, Kocaeli, Turkiye., Babaoglu A; Department of Pediatric Cardiology, Kocaeli University Faculty of Medicine, Kocaeli, Turkiye.
Jazyk:	angličtina
Zdroj:	Northern clinics of Istanbul [North Clin Istanb] 2024 Aug 02; Vol. 11 (4), pp. 315-321. Date of Electronic Publication: 2024 Aug 02 (Print Publication: 2024).
DOI:	10.14744/nci.2023.64920
Abstrakt:	Objective: Postural orthostatic tachycardia syndrome (POTS) is one of the orthostatic intolerance syndromes that are common in young adolescents and impair quality of life. POTS is a multi-systemic disease. Many mechanisms have been defined in POTS etiology, such as autonomic denervation, hypovolemia, hyperadrenergic stimulation, low condition, and hypervigilance. Recently, mast cell activation (MCA) has also been on the agenda in etiology. There are few studies in the literature on the relationship between MCA and POTS in adulthood. However, data on children and adolescents is limited. In light of this information, we aimed to evaluate the relationship between POTS and MCA by measuring serum tryptase levels, a specific marker for MCA. Methods: This prospective study included patients who were admitted to Kocaeli University Faculty of Medicine Hospital Pediatric Cardiology outpatient clinic for syncope-presyncope between November 2018 and August 2019. Patients who underwent the TILT-table test were enrolled in the study. Patients with structural heart disease or chronic heart disease were not included in this study. Serum tryptase levels were obtained from all patients before the TILT-table test, and serum tryptase levels were re-studied after the test was terminated in patients with positive TILT-table tests for POTS. Patients diagnosed with POTS were classified as Group 1, and other patients were classified as Group 2. Results: Twenty-eight of the 58 patients included in the study (mean: 14.4±2.0 years; 38 girls, 20 boys) were diagnosed with POTS. The remaining 30 patients were diagnosed with vasovagal syncope and included in Group 2. The increase in mean heart rate during the test was 38±6 beats/min and 47.05%±15.65% in patients with POTS. Basal serum tryptase levels were not different between groups (3.2±1.3 ng/ml and 3.84±1.78 ng/ml, respectively; p=0.129), while serum tryptase levels (both baseline and after 45-60 min of the TILT-table test) were higher in patients presenting with symptoms related to MCA compared to others. Conclusion: In the literature, MCA was considered to be one of the mechanisms leading to POTS. Although other mechanisms, such as neuropathic and hypovolemic POTS, may be active in the patients, the symptoms of MCA in these patients should be routinely questioned. Competing Interests: No conflict of interest was declared by the authors.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu